GlassScriptPhysician profile
Adriana Palumbo
NPI 1841233418
$3,016.29
in general payments reported to CMS, 2019-2025
17 companies · $649 in 2025
The $649 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $560 · 2021: $308 · 2022: $295 · 2023: $402 · 2024: $440 · 2025: $649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,143.55 | 2019-2025 | Precision7, Total30, Precision 1 |
| Sight Sciences, INC. | $527.93 | 2019-2025 | Tearcare System, Omni Surgical System |
| Glaukos Corporation | $391.39 | 2023-2024 | Idose, Kxl System (Not Refurbished) |
| Eyevance Pharmaceuticals LLC | $149.83 | 2022 | |
| Rxsight INC | $147.03 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Aerie Pharmaceuticals, INC. | $126.79 | 2021 | |
| Abbvie INC. | $124.73 | 2023 | |
| Coopervision INC. | $112.48 | 2019-2020 | |
| Johnson & Johnson Vision Care, INC. | $58.81 | 2019-2023 | Acuvue |
| Optos, INC. | $41.46 | 2019 | |
| Bausch & Lomb Americas INC. | $38.57 | 2025 | Miebo |
| Abb Con-Cise Optical Group LLC | $37.29 | 2023 | Contact Lens, Spectacle Lenses |
| Carl Zeiss Meditec Ag | $34.40 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $29.42 | 2024-2025 | Xdemvy |
| Allergan, INC. | $25.00 | 2020-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $14.21 | 2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $13.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adriana Palumbo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.